Bristol Myers Squibb’s Opdivo-Yervoy combo is awaiting some critical decisions in non-small cell lung cancer, but in the […]

As the U.S. economic toll from COVID-19 lockdowns continue to mount—with tens of millions out of work and businesses suffering—discussion has […]

As a partner with Novartis on JAK inhibitor Jakafi, Incyte has pinned its future fortunes on the success […]

As an ex-army surgeon and a military historian, we have previously felt uneasy about healthcare workers being described […]

The data is being used by researchers to evaluate the effectiveness of a number of potential treatments

Study aiming to enrol 3,000 patients via more than 100 GP surgeries

Frontline workers now eligible for testing will include the police, the fire service, frontline benefits workers and those […]

The agency concluded that the risks of the medicine outweigh its benefits

Incyte’s Pemazyre can now be used to treat the bile duct cancer. The firm has also launched a […]

AstraZeneca investors are once again taking issues with CEO Pascal Soriot’s compensation package, just like they have repeatedly […]